Aquestive Therapeutics, Inc. - Common Stock (NQ:AQST)
Price and Volume
Detailed Quote| Volume | 2,304,917 |
| Open | 3.860 |
| Bid (Size) | 4.040 (5,000) |
| Ask (Size) | 4.200 (1,100) |
| Prev. Close | 4.000 |
| Today's Range | 3.860 - 4.240 |
| 52wk Range | 2.120 - 7.550 |
| Shares Outstanding | 38,886,465 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Top movers in Monday's session ↗
February 02, 2026
Monday's session: top gainers and losers ↗
February 02, 2026
Monday's session: gap up and gap down stocks ↗
February 02, 2026
Why Did AQST Stock Jump 35% Today? ↗
February 02, 2026
Monday's pre-market session: top gainers and losers ↗
February 02, 2026
Frequently Asked Questions
Is Aquestive Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aquestive Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aquestive Therapeutics, Inc. - Common Stock trade on?
Aquestive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aquestive Therapeutics, Inc. - Common Stock?
The ticker symbol for Aquestive Therapeutics, Inc. - Common Stock is AQST on the Nasdaq Stock Market
What is the current price of Aquestive Therapeutics, Inc. - Common Stock?
The current price of Aquestive Therapeutics, Inc. - Common Stock is 4.210
When was Aquestive Therapeutics, Inc. - Common Stock last traded?
The last trade of Aquestive Therapeutics, Inc. - Common Stock was at 03/02/26 04:00 PM ET
What is the market capitalization of Aquestive Therapeutics, Inc. - Common Stock?
The market capitalization of Aquestive Therapeutics, Inc. - Common Stock is 163.71M
How many shares of Aquestive Therapeutics, Inc. - Common Stock are outstanding?
Aquestive Therapeutics, Inc. - Common Stock has 164M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.